[1]张舒扬.阿奇霉素联合头孢地嗪对急性细菌性痢疾患儿白细胞计数及C-反应蛋白水平的影响[J].医学信息,2022,35(06):165-167.[doi:10.3969/j.issn.1006-1959.2022.06.043]
　ZHANG Shu-yang.Effect of Azithromycin Combined with Cefodizime on White Blood Cell Count and C-reactive Protein Level in Children with Acute Bacillary Dysentery[J].Medical Information,2022,35(06):165-167.[doi:10.3969/j.issn.1006-1959.2022.06.043]
点击复制

阿奇霉素联合头孢地嗪对急性细菌性痢疾患儿白细胞计数及C-反应蛋白水平的影响()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
35卷
期数:
2022年06期
页码:
165-167
栏目:
药物与临床
出版日期:
2022-03-15

文章信息/Info

Title:
Effect of Azithromycin Combined with Cefodizime on White Blood Cell Count and C-reactive Protein Level in Children with Acute Bacillary Dysentery
文章编号:
1006-1959（2021）06-0165-03
作者:
张舒扬
（佳木斯市中心医院儿科，黑龙江 佳木斯 154000）
Author(s):
ZHANG Shu-yang
(Department of Pediatrics,Jiamusi Central Hospital,Jiamusi 154000,Heilongjiang,China)
关键词:
急性细菌性痢疾; 头孢地嗪; 阿奇霉素; 白细胞计数; C-反应蛋白
Keywords:
Acute bacillary dysentery; Cefodizime; Azithromycin; White blood cell count; C-reactive protein
分类号:
R975；R28
DOI:
10.3969/j.issn.1006-1959.2022.06.043
文献标志码:
A
摘要:
目的 研究阿奇霉素联合头孢地嗪对急性细菌性痢疾（BD）患儿白细胞计数（WBC）及C-反应蛋白水平（CRP）的影响。方法 选取2020年5月-2021年5月佳木斯市中心医院儿科收治的82例急性BD患儿，按照随机数字表法分为对照组与观察组，各41例。两组均给予常规对症治疗，在此基础上对照组采用阿奇霉素治疗，观察组采用阿奇霉素联合头孢地嗪治疗，比较两组治疗效果、症状恢复时间、免疫功能指标、WBC及CRP水平、不良反应。结果 观察组治疗有效率为87.80%，高于对照组的70.73%，差异有统计学意义（P＜0.05）；观察组各项症状恢复时间均短于对照组（P＜0.05）；两组CD3+、CD4+水平高于治疗前，且观察组高于对照组，而CD8+低于治疗前，且观察组低于对照组，差异有统计学意义（P＜0.05）；两组WBC、CRP水平低于治疗前，且观察组低于对照组（P＜0.05）；观察组与对照组的不良反应发生率分别为14.63%、9.76%，差异无统计学意义（P＞0.05）。结论 阿奇霉素联合头孢地嗪治疗急性BD效果显著，可缩短患儿症状改善时间，缓解炎性反应，同时促进机体免疫功能的恢复，且不良反应少。
Abstract:
Objective To study the effect of azithromycin combined with cefodizime on white blood cell count (WBC) and C-reactive protein (CRP) in children with acute bacillary dysentery (BD).Methods A total of 82 children with acute BD admitted to Jiamusi Central Hospital from May 2020 to May 2021 were selected and randomly divided into control group and observation group, with 41 cases in each group. Both groups were given conventional symptomatic treatment. On this basis, the control group was treated with azithromycin, and the observation group was treated with azithromycin combined with cefodizime. The therapeutic effect, symptom recovery time, immune function indexes, WBC and CRP levels, and adverse reactions were compared between the two groups.Results The effective rate of the observation group was 87.80%, which was higher than 70.73% of the control group, and the difference was statistically significant (P<0.05). The recovery time of each symptom in the observation group was shorter than that in the control group (P<0.05). After treatment, the levels of CD3+ and CD4+ in the two groups were higher than those before treatment, and the observation group was higher than the control group, while CD8+ was lower than that before treatment, and the observation group was lower than the control group, the difference was statistically significant (P<0.05). After treatment, the levels of WBC and CRP in the two groups were lower than those before treatment, and those in the observation group were lower than the control group (P<0.05). The incidence of adverse reactions in the observation group and the control group was 14.63% and 9.76%, respectively, and the difference was not statistically significant (P>0.05).Conclusion Azithromycin combined with cefodizime is effective in the treatment of acute BD, which can shorten the time of symptom improvement, alleviate inflammatory reaction, and promote the recovery of immune function, with less adverse reactions.

参考文献/References:

[1]刘策,涂银萍,白书媛,等.临床诊断急性细菌性痢疾的流行病学、病原学及临床特点[J].医学动物防制,2017,33(1):40-43.[2]沈波燕,柴能民,赵志豪.小儿急性细菌性痢疾发病影响因素及病原菌分布和耐药性特征[J].中国妇幼保健,2021,36(7):1558-1560.[3]Houpt ER,Ferdous T,Ara R,et al.Clinical Outcomes of Drug-resistant Shigellosis Treated With Azithromycin in Bangladesh[J].Clin Infect Dis,2021,72(10):1793-1798.[4]祖丽皮亚·莫明,迪力木拉提·吾拉木.头孢哌酮钠治疗细菌性痢疾的临床效果[J].临床合理用药杂志,2020,13(29):65-66.[5]杨锡强,易著文.儿科学[M].6版.北京:人民卫生出版社,2009:292-301.[6]陆迪雅,许磊,马兰,等.小儿急性细菌性痢疾的病原菌分布特征及耐药性分析[J].传染病信息,2020,33(2):176-178,182.[7]王小锐,徐贞贞.头孢哌酮-舒巴坦与阿奇霉素联用对支原体肺炎患者伴细菌感染的临床疗效及其经济学分析[J].抗感染药学,2019,16(3):441-443.[8]彭建平.阿奇霉素不同途径给药对儿科患者抗感染治疗的临床疗效与不良反应的影响[J].抗感染药学,2019,16(2):241-243.[9]Al-Ouqaili M,Bahr AA.Molecular Detection of Shigella spp. and Entamoeba histolytica Causing Bacillary and Amoebic Dysentery Among Children in Ramadi City[J].Al-Anbar Medical Jouinal,2018,14(1):64-74.[10]黎佩珍.阿莫西林与头孢派酮治疗细菌性痢疾疗效的临床对照研究[J].齐齐哈尔医学院学报,2015,36(32):4886-4888.[11]潘婧,江涛,吴熙,等.应用不同抗菌药物治疗细菌性痢疾的效果及对CRP、TNF-α的影响[J].检验医学与临床,2017,14(23):3520-3522,3563.[12]肖兰春.头孢哌酮治疗细菌性痢疾的临床效果分析[J].中外医学研究,2017,15(25):135-136.[13]安正红.C-反应蛋白与儿童急性细菌性痢疾的诊断和治疗[J].吉林医学,2018,39(5):934-935.[14]李绪民,吴爱娟.微生态制剂对细菌性痢疾的辅助治疗及对患者血清C反应蛋白水平的影响[J].中国微生态学杂志,2020,32(3):283-285,289.[15]张洪宾,李亮.金荞麦片联合头孢地尼治疗急性细菌性痢疾的临床研究[J].现代药物与临床,2019,34(2):499-503.

更新日期/Last Update: 1900-01-01